Clinical predictors of survival in patients with castration-resistant prostate treated with sipuleucel-T cellular immunotherapy.
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 22 Jul 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.